US Broker Ratings

Guardant Health, Inc. (GH) Stock Analysis: Unlocking Potential in Precision Oncology with a Robust Revenue Growth

Guardant Health, Inc. (NASDAQ: GH) stands at the forefront of the precision oncology field, offering groundbreaking diagnostic and research services that hold significant promise for both patients and investors. With..

ResMed Inc. (RMD) Stock Analysis: Navigating the Sleep Health Giant’s 13.49% Potential Upside

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry, has garnered attention from investors due to its robust market presence..

Bio-Techne Corp (TECH) Stock Analysis: Navigating a Competitive Biotech Landscape with Strategic Growth Potential

Bio-Techne Corporation (NASDAQ: TECH) stands as a prominent player in the biotechnology industry, a sector characterized by rapid innovation and intense competition. With a market capitalization of $10.7 billion, the..

Legend Biotech Corporation (LEGN) Stock Analysis: A Biotech with a Staggering 218% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is capturing the attention of investors in the biotechnology sector with its impressive growth potential and innovative approach to cancer treatment. With a market capitalization..

Illumina, Inc. (ILMN) Stock Analysis: Navigating a Tightrope Between Innovation and Valuation

Illumina, Inc. (NASDAQ: ILMN) stands as a pivotal player in the healthcare sector, specifically within diagnostics and research. With a market capitalization of $21.77 billion, Illumina has carved out a..

Neurocrine Biosciences, Inc. (NBIX): Exploring a 35.65% Potential Upside in the Healthcare Sector

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stands at a fascinating juncture within the healthcare sector, specifically in the drug manufacturing industry. With a substantial market capitalization of $13.2 billion, this San..

Stevanato Group S.p.A. (STVN) Stock Analysis: A 44.84% Potential Upside Holds Investor Attention

For investors seeking opportunities in the healthcare sector, Stevanato Group S.p.A. (NYSE: STVN) presents a compelling case. The Italian-based company, with a market capitalization of $5.39 billion, operates within the..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring an 18.73% Potential Upside with Strong Buy Ratings

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), headquartered in Carlsbad, California, stands as a significant player in the biotechnology sector, specifically within the healthcare industry. With a market capitalization of $12.36 billion,..

Insmed Incorporated (INSM): Analyst Consensus Highlights 32% Potential Upside in Biotech Stock

Insmed Incorporated (NASDAQ: INSM) has drawn significant attention in the biotechnology sector with its innovative approach to treating serious and rare diseases. As the company continues to push the boundaries..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring a 10.78% Upside in the Healthcare Diagnostics Sector

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, is capturing the attention of investors with its robust diagnostic and research services. With a current market capitalization..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 16.19% Potential Upside Amidst Strong Buy Ratings

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector specializing in neurological and neurodegenerative diseases, presents an intriguing opportunity for investors seeking exposure to cutting-edge biopharmaceuticals. With a market..

Avantor, Inc. (AVTR)

⚠️ No article content returned.

..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Insights: Evaluating a 13.85% Potential Upside

As investors navigate an increasingly complex healthcare market, Dr. Reddy’s Laboratories Ltd (NYSE: RDY) presents an intriguing opportunity with its substantial market presence and a noteworthy potential upside of 13.85%...

Edwards Lifesciences (EW) Stock Analysis: Exploring a 14.63% Upside Potential

Edwards Lifesciences Corporation (NYSE: EW), a stalwart in the healthcare sector specializing in medical devices, is capturing the attention of investors with a promising 14.63% potential upside based on current..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a 15% Upside with Strong Analyst Confidence

The Ensign Group, Inc. (NASDAQ: ENSG) is a healthcare titan with a market capitalization of $10.46 billion, operating within the Medical Care Facilities industry. The company, headquartered in San Juan..

Repligen Corporation (RGEN) Stock Analysis: A Look at 17.82% Potential Upside in the Bioprocessing Market

Repligen Corporation (NASDAQ: RGEN), with its roots deep in the healthcare sector, finds itself in a promising position within the medical instruments and supplies industry. As a key player in..

Tenet Healthcare (THC) Stock Analysis: A 20.8% Potential Upside Beckons Investors

Tenet Healthcare Corporation (NYSE: THC) stands out in the healthcare sector, not just for its expansive operations but also for the significant investment potential it currently presents. With a market..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring the 16.73% Potential Upside in Biotech

Roivant Sciences Ltd. (NASDAQ: ROIV), a London-based clinical-stage biopharmaceutical company, continues to captivate investors with its innovative approach to drug discovery and development, particularly in the biotechnology sector. With its..

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a 10.48% Potential Upside in the Healthcare Sector

For investors looking to deepen their portfolios in the healthcare sector, The Cooper Companies, Inc. (NYSE: COO) presents an intriguing option. With a market capitalization of $16.38 billion, Cooper Companies..

DaVita Inc. (DVA) Stock Analysis: Unpacking a 36.53% Potential Upside in the Healthcare Sector

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specializes in providing kidney dialysis services across the United States. With a market capitalization of $7.49 billion, DaVita stands..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds